Search clinical trials for: HIVIS DNA Cervarix and MVA-CMDR

Total 43 results

Henry M. Jackson Foundation for the Advancement...
Johns Hopkins University; Karolinska Institutet; University of Miami; Chulalongkorn... and other collaborators

Active, not recruiting

Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and Youth (HVRRICANE)

HIV Infections

South Africa
Instituto Nacional de Saúde, Mozambique
European and Developing Countries Clinical Trials Partnership (EDCTP); Swedish...

Completed

Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine

HIV Infections

Mozambique
Muhimbili University of Health and Allied Sciences
Karolinska Institutet; Imperial College London; Medical Research Council; Ludwig-Maximilians... and other collaborators

Completed

A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique (TaMoVac II)

HIV | Safety | Immunogenicity | Vaccines

Tanzania, Mozambique
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network; IPPOX Foundation; CHAVI; MHRP

Completed

Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults

HIV Infections

United States, Switzerland
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults

HIV Infections

Uganda, United States, Kenya, Tanzania
Rockefeller University

Completed

A Phase I Study to Evaluate the Safety and Immunogenicity of Heterologous Boost Immunizations With MVA-CMDR

HIV

United States
U.S. Army Medical Research and Development Command

Completed

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

HIV Infections

United States
HIV Vaccine Trials Network
South Africa AIDS Vaccine Initiative

Completed

Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults

HIV Seronegativity | HIV Preventive Vaccine

South Africa
Imperial College London
Medical Research Council; Wellcome Trust

Completed

Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses (UKHVCSpoke003)

HIV

United Kingdom
National Institute of Allergy and Infectious Diseases...

Withdrawn

Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications

HIV Infections
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults

HIV Infections

United States
SkinJect, Inc.

Terminated

Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC)

Basal Cell Carcinoma

United States
National Institute of Allergy and Infectious Diseases...

Completed

Early Immune Responses to Vaccination - A Substudy to HVTN 205

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
GeoVax, Inc.

Completed

Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults

HIV Infections

United States
Rigshospitalet, Denmark

Recruiting

Culprit Lesions in NSTEMI With Multi Vessel Disease (NSTEMI-CULPRIT) (NS-CULPRIT)

NSTEMI - Non-ST Segment Elevation MI | Multi Vessel Coronary Artery Disease

Denmark
National Institute of Allergy and Infectious Diseases...
University of Maryland, Baltimore; Duke University; HIV Vaccine Trials Network... and other collaborators

Withdrawn

Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult Participants

HIV Infections
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults

HIV Infections

United States, Peru
National Institute of Allergy and Infectious Diseases...

Withdrawn

CS DNA MVA Trial in Mampong, Ghana

Plasmodium Falciparum Malaria

Ghana, United States
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

HIV Infections

United States, South Africa
GeoVax, Inc.
University of Alabama at Birmingham; AIDS Research Consortium of Atlanta; AIDS...

Completed

A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART

HIV-1 Infection

United States
Mansoura University Hospital

Unknown

Extracranial Carotid & Intracranial Arterial Stenosis in Ischemic Stroke

Ischemic Stroke | Carotid Stenosis

Egypt
Fondazione Don Carlo Gnocchi Onlus

Completed

Nutritional Status in Subacute Stroke Patients Under Rehabilitation (Nutristroke)

Stroke

Italy
Pharmena North America

Completed

Safety of a Hypolipidemic Agent in Healthy Normal Volunteers (PNAI-002)

Hyperlipidemia

United States
SkinJect, Inc.

Active, not recruiting

Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)

Basal Cell Carcinoma

United States
Solid Biosciences Inc.

Completed

Evaluation of Home Based Assessments on Participants With DMD

Duchenne Muscular Dystrophy

United States
Cortria Corporation

Completed

The Safety of a Hypolipidemic Agent in Healthy Normal Volunteers (Cortria-002)

Healthy
Falo, Louis, MD
National Cancer Institute (NCI)

Recruiting

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) (cSCC)

Cutaneous Squamous Cell Carcinoma | Skin Cancers - Squamous Cell Carcinoma

United States
AVAX Technologies

Completed

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

Melanoma

United States
Medical University of Vienna

Terminated

Study Investigating the Levels and Effects of Low-grade Inflammation in Diabetic Retinopathy of Type 1 Diabetes

Inflammation | Diabetic Retinopathy

Austria
Fondazione Don Carlo Gnocchi Onlus

Not yet recruiting

Nutritional Status in Subacute Stroke Patients Under Rehabilitation 2.0 (Nutristroke2)

Stroke

Italy
Technical University of Munich
Ludwig-Maximilians - University of Munich

Recruiting

All Eyes on PCS - Analysis of the Retinal Microvasculature in Patients With Post-COVID-19 Syndrome

Endothelial Dysfunction | Long Covid19 | Post COVID-19 Condition

Germany
Cortria Corporation
PPD; Pharmena North America

Completed

Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions

Healthy

Canada
MRC/UVRI and LSHTM Uganda Research Unit
King's College London; Karolinska Institutet; Gilead Sciences; Imperial College... and other collaborators

Enrolling by invitation

A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP (PrEPVacc)

HIV Infections

Uganda
Medical University of Vienna

Recruiting

Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

COVID-19 | Post-COVID-19 Syndrome

Austria
Murielle Surquin

Completed

Interest of a Tongue Strength Measurement in the Screening for Sarcopenia in Hospitalized Elderly Patients

Sarcopenia

Belgium
Cardiocentro Ticino

Completed

Predictors of Postoperative Delirium After Transcatheter Aortic Valve Implantation

Postoperative Delirium

Switzerland
Medical University of Vienna

Withdrawn

Effect of Simvastatin Withdrawal on Ocular Endothelial Function

Healthy

Austria
Ospedale San Raffaele

Unknown

Fundus Oculi and Erectile Dysfunction

Erectile Dysfunction

Italy
Falo, Louis, MD

Active, not recruiting

Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) (MNA-D)

Cutaneous T Cell Lymphoma

United States
Centre Hospitalier Universitaire Dijon

Recruiting

Loss of Autonomy in the Elderly: Relationships Between Gut Microbiota Diversity, Nutrition and Cognitive and Sensory-motor Disturbances in "Small Eaters" and "Non Small Eaters" (ALMICO)

Elderly Small Eater

France
National Institute of Allergy and Infectious Diseases...
Rho Federal Systems Division, Inc.; Autoimmunity Centers of Excellence

Completed

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Systemic Lupus Erythematosus (SLE) | Multiple Sclerosis (MS) | Rheumatoid Arthritis (RA) | Juvenile Dermatomyositis (JDM) | Juvenile Idiopathic Arthritis (JIA) | Pemphigus Vulgaris | Systemic Sclerosis (SSc) | Pediatric SLE | Pediatric-Onset Multiple Sclerosis (POMS)

United States
Hungarian Institute of Cardiology
Semmelweis University

Unknown

Frailty and Cognitive Function Assessment of TAVI Patients

Quality of Life | Aortic Valve Stenosis | Heart Valve Disease

Hungary
National Cancer Institute (NCI)

Completed

Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia

Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia

United States, Canada

Search clinical trials for: HIVIS DNA Cervarix and MVA-CMDR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations